Aurisco Pharmaceutical Co., Ltd.

Manufacturer of generic and complex active ingredients and of finished dosage forms, covering small molecules, peptides and oligonucleotides. It reports four plants — Shanghai, Yangzhou and two at Tiantai — and five R&D centres with over 300 scientists in complex synthesis, synthetic biology and photochemistry. Founded in 1998. Commercial subsidiaries in the United States, Europe, India and South America.